[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Viatris Inc (VTRS)

Viatris Inc (VTRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,935,632
  • Shares Outstanding, K 1,164,553
  • Annual Sales, $ 14,300 M
  • Annual Income, $ -3,515 M
  • EBIT $ 139 M
  • EBITDA $ 5,875 M
  • 60-Month Beta 0.88
  • Price/Sales 1.31
  • Price/Cash Flow 2.21
  • Price/Book 1.29

Options Overview Details

View History
  • Implied Volatility 30.87% (+0.89%)
  • Historical Volatility 37.00%
  • IV Percentile 19%
  • IV Rank 16.04%
  • IV High 54.04% on 02/18/26
  • IV Low 26.44% on 12/23/25
  • Expected Move (DTE 19) 0.82 (5.07%)
  • Put/Call Vol Ratio 0.46
  • Today's Volume 721
  • Volume Avg (30-Day) 4,537
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 146,479
  • Open Int (30-Day) 146,831
  • Expected Range 15.44 to 17.08

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.63
  • Number of Estimates 4
  • High Estimate $0.63
  • Low Estimate $0.62
  • Prior Year $0.62
  • Growth Rate Est. (year over year) +1.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.77 +10.05%
on 05/01/26
17.53 -7.24%
on 05/14/26
+1.29 (+8.62%)
since 04/29/26
3-Month
12.87 +26.34%
on 03/30/26
17.53 -7.24%
on 05/14/26
+1.33 (+8.91%)
since 02/27/26
52-Week
8.40 +93.57%
on 06/03/25
17.53 -7.24%
on 05/14/26
+7.67 (+89.29%)
since 05/28/25

Most Recent Stories

More News
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky

1 Unpopular Stock That Should Get More Attention and 2 We Find Risky

MSM : 109.47 (-0.28%)
VTRS : 16.26 (+0.93%)
PL : 51.14 (-0.51%)
Viatris (VTRS): Buy, Sell, or Hold Post Q1 Earnings?

Viatris (VTRS): Buy, Sell, or Hold Post Q1 Earnings?

VTRS : 16.26 (+0.93%)
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain

FDA PDUFA Goal Date Set for Dec. 27, 2026

VTRS : 16.26 (+0.93%)
1 Stock Under $50 to Target This Week and 2 We Avoid

1 Stock Under $50 to Target This Week and 2 We Avoid

ZUMZ : 24.63 (-2.73%)
VTRS : 16.26 (+0.93%)
LC : 17.85 (+4.82%)
5 Revealing Analyst Questions From Viatris’s Q1 Earnings Call

5 Revealing Analyst Questions From Viatris’s Q1 Earnings Call

VTRS : 16.26 (+0.93%)
3 Unprofitable Stocks That Fall Short

3 Unprofitable Stocks That Fall Short

NNBR : 2.97 (-3.57%)
VTRS : 16.26 (+0.93%)
MRCY : 111.70 (+3.32%)
VTRS Q1 Deep Dive: China Strength, R&D Pipeline, and Execution Drive Outperformance

VTRS Q1 Deep Dive: China Strength, R&D Pipeline, and Execution Drive Outperformance

VTRS : 16.26 (+0.93%)
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference

PITTSBURGH , May 7, 2026 /PRNewswire/ -- Viatris Inc . (Nasdaq: VTRS), a global healthcare company, today announced that the Company will present at the Bank of America Securities 2026 Healthcare...

VTRS : 16.26 (+0.93%)
Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue

Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue

VTRS : 16.26 (+0.93%)
Viatris: Q1 Earnings Snapshot

Viatris: Q1 Earnings Snapshot

VTRS : 16.26 (+0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor...

See More

Key Turning Points

3rd Resistance Point 16.81
2nd Resistance Point 16.55
1st Resistance Point 16.41
Last Price 16.26
1st Support Level 16.01
2nd Support Level 15.75
3rd Support Level 15.61

See More

52-Week High 17.53
Last Price 16.26
Fibonacci 61.8% 14.04
Fibonacci 50% 12.97
Fibonacci 38.2% 11.89
52-Week Low 8.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.